Call to arrange a consultation
+1 416 777 0888

Galderma Canada Inc. et al. v Sandoz Canada Inc.

2020
T-886-20
Pending
New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent Nos. 2,440,472, 2,521,885, and 2,803,922 (doxycycline)

Counsel to: 
Sandoz Canada Inc.
here.

Meet the team

Arrow down